Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.88
(
-0.64%
)
Bitcoin
79,053.00
(
0.51%
)
News Focus
News Focus
Post# of 517600
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 170
Posts 23065
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: tradeherpete post# 293261

Monday, 01/18/2021 4:27:01 PM

Monday, January 18, 2021 4:27:01 PM

Post# of 517600
Much of the NDA for the three separate NDA's will be the same information.

The manufacturing facility information etc. will be the same. They might include the P1 data from all three trials in each NDA.

My understanding at this time is that an NDA would be required for each indication.

P2 & P3 information will be unique to each NDA as will the labeling and probably the dosing schedules.

The American Republic will endure until the day Congress discovers that it can bribe the public with the it's own money.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News